Cargando…
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
Yellow fever (YF) remains a threat to global health, with an increasing number of major outbreaks in the tropical areas of the world over the recent past. In light of this, the Eliminate Yellow Fever Epidemics Strategy was established with the aim of protecting one billion people at risk of YF throu...
Autores principales: | Mokaya, Jolynne, Kimathi, Derick, Lambe, Teresa, Warimwe, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235545/ https://www.ncbi.nlm.nih.gov/pubmed/34207358 http://dx.doi.org/10.3390/vaccines9060671 |
Ejemplares similares
-
Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
por: Kimathi, Derick, et al.
Publicado: (2019) -
The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis
por: Nyamwaya, Doris K., et al.
Publicado: (2022) -
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
por: Juan-Giner, Aitana, et al.
Publicado: (2021) -
The Present and Future of Yellow Fever Vaccines
por: Hansen, Clairissa A., et al.
Publicado: (2021) -
Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)